Pre-Mortem Review
An independent pre-decision review of a major China-related strategy, investment, or operating initiative, with findings delivered in a structured diagnostic report.
Diagnosis, not validation.
Some China-related business decisions look acceptable on paper because the case has not been independently tested.
A Pre-Mortem Review tests the assumptions the decision relies on, and constructs the failure scenario from the gaps.
When To Use It
A China-related strategy is under consideration but not yet approved
An investment is being evaluated and has not yet been committed
A partner, structure, or operating model is on the table but has not been independently tested
An external view is needed before a board, investment committee, or formal commitment
What You Get
A structured PDF report with an executive conclusion, the key findings behind it, the cost of not acting, a recommended action, and a categorical decision.
Final report within 10 working days of receiving the agreed materials and completing the initial review call. A 30–60 minute debrief call is included.
What It Is Not
This is not market research, general advisory, or implementation support. It is a fixed-scope pre-decision review of a specific China-related strategy, investment, or operating move.
Pricing and Booking
Price: USD 6,500
If the decision is important, review it before committing.